Generali Investments, Management Co LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 2043136
LJUBLJANA, 2A
Position in ALNY
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$284,774
-$121,203 QoQ
Shares Held
946
-22.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#31
of 70 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Generali Investments, Management Co LLC holds $6,891,697 across 5 Biotechnology names. ALNY ranks #5 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,926 | $2,446,891 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,000 | $2,279,760 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
|
33,149 | $1,084,635 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,276 | $795,637 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
946 | $284,774 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $284,774 | 946 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $405,977 | 1,227 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $383,732 | 965 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||